Literature DB >> 7854895

Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients.

D C Johnson1, F L Johnson, S Goldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7854895     DOI： 10.1097/00006454-199410000-00015

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  20 in total

1.  Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports).

Authors:  T U Anthony; L G Rubin
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

3.  Reducing central line infections in pediatric and neonatal patients.

Authors:  Simon Li; Edward Vincent S Faustino; Sergio G Golombek
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

4.  Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique.

Authors:  Y Haimi-Cohen; N Husain; J Meenan; G Karayalcin; M Lehrer; L G Rubin
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

5.  Predictors and outcome of catheter-related bacteremia in children on chronic hemodialysis.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Sheila Coakley; Carolyn Abitbol; Brenda Montane; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2006-08-01       Impact factor: 3.714

6.  Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections.

Authors:  Andrew D G Van Praagh; Tongchuan Li; Shuxin Zhang; Anu Arya; Liping Chen; Xi-Xian Zhang; Shellie Bertolami; Lawrence I Mortin
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

7.  Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm.

Authors:  Issam Raad; Hend Hanna; Tanya Dvorak; Gassan Chaiban; Ray Hachem
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

Review 8.  Antifungal lock therapy.

Authors:  Carla J Walraven; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

9.  Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy.

Authors:  Matthew K Schinabeck; Lisa A Long; Mohammad A Hossain; Jyotsna Chandra; Pranab K Mukherjee; Sotohy Mohamed; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 10.  Management of invasive candidiasis in critically ill patients.

Authors:  Stijn Blot; Koenraad Vandewoude
Journal:  Drugs       Date:  2004       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.